Takeda Research Development from 2010 to 2024

TAK Stock  USD 13.37  0.10  0.75%   
Takeda Pharmaceutical Research Development yearly trend continues to be quite stable with very little volatility. The value of Research Development is projected to decrease to about 450.8 B. From the period between 2010 and 2024, Takeda Pharmaceutical, Research Development regression line of its data series had standard deviation of  126,203,158,407 and standard deviation of  126,203,158,407. View All Fundamentals
 
Research Development  
First Reported
2008-09-30
Previous Quarter
183.9 B
Current Value
187.4 B
Quarterly Volatility
34.1 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Takeda Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Takeda main balance sheet or income statement drivers, such as Depreciation And Amortization of 867.8 B, Interest Expense of 204.9 B or Selling General Administrative of 760.9 B, as well as many exotic indicators such as Price To Sales Ratio of 0.92, Dividend Yield of 0.0775 or PTB Ratio of 0.59. Takeda financial statements analysis is a perfect complement when working with Takeda Pharmaceutical Valuation or Volatility modules.
  
This module can also supplement Takeda Pharmaceutical's financial leverage analysis and stock options assessment as well as various Takeda Pharmaceutical Technical models . Check out the analysis of Takeda Pharmaceutical Correlation against competitors.

Latest Takeda Pharmaceutical's Research Development Growth Pattern

Below is the plot of the Research Development of Takeda Pharmaceutical Co over the last few years. It is Takeda Pharmaceutical's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Takeda Pharmaceutical's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Takeda Research Development Regression Statistics

Arithmetic Mean422,347,003,333
Geometric Mean407,426,309,155
Coefficient Of Variation29.88
Mean Deviation100,349,604,000
Median368,298,000,000
Standard Deviation126,203,158,407
Sample Variance15927237192T
Range416B
R-Value0.78
Mean Square Error6718268770.4T
R-Squared0.61
Significance0.0006
Slope22,010,048,571
Total Sum of Squares222981320687.9T

Takeda Research Development History

2024450.8 B
2023728.3 B
2022633.3 B
2021526.1 B
2020455.8 B
2019492.4 B
2018368.3 B

About Takeda Pharmaceutical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Takeda Pharmaceutical income statement, its balance sheet, and the statement of cash flows. Takeda Pharmaceutical investors use historical funamental indicators, such as Takeda Pharmaceutical's Research Development, to determine how well the company is positioned to perform in the future. Although Takeda Pharmaceutical investors may use each financial statement separately, they are all related. The changes in Takeda Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Takeda Pharmaceutical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Takeda Pharmaceutical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Takeda Pharmaceutical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development728.3 B450.8 B
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Takeda Pharmaceutical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Takeda Pharmaceutical's short interest history, or implied volatility extrapolated from Takeda Pharmaceutical options trading.

Currently Active Assets on Macroaxis

When determining whether Takeda Pharmaceutical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Takeda Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Takeda Pharmaceutical Co Stock. Highlighted below are key reports to facilitate an investment decision about Takeda Pharmaceutical Co Stock:
Check out the analysis of Takeda Pharmaceutical Correlation against competitors.
Note that the Takeda Pharmaceutical information on this page should be used as a complementary analysis to other Takeda Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Takeda Stock analysis

When running Takeda Pharmaceutical's price analysis, check to measure Takeda Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutical is operating at the current time. Most of Takeda Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takeda Pharmaceutical's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges
Is Takeda Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Takeda Pharmaceutical. If investors know Takeda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Takeda Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.12)
Dividend Share
184
Earnings Share
0.36
Revenue Per Share
1.3 K
Quarterly Revenue Growth
0.013
The market value of Takeda Pharmaceutical is measured differently than its book value, which is the value of Takeda that is recorded on the company's balance sheet. Investors also form their own opinion of Takeda Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Takeda Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Takeda Pharmaceutical's market value can be influenced by many factors that don't directly affect Takeda Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Takeda Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Takeda Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Takeda Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.